CERS Stock Analysis: Buy, Sell, or Hold?
CERS - Cerus Corp
$2.59
-0.01 (-0.38%)
▼
5d:
+2.78%
30d:
-5.47%
90d:
+42.31%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When CERS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CERS shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: CERS shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CERS is currently trading at $2.59, which is considered fair relative to its 30-day fair value range of $2.51 to $2.81.
Technical Outlook: Technically, CERS is in a uptrend. Immediate support is located at $2.41, while resistance sits at $2.73.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.67 (+80.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CERS is in a uptrend. Immediate support is located at $2.41, while resistance sits at $2.73.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.67 (+80.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.51 -
$2.81
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 80.2% below Wall St target ($4.67)
Trading Range Analysis
30-Day Trading Range
$2.51 -
$2.81
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.41
Resistance Level
$2.73
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Wall Street Target
$4.67
(+80.2%)
Revenue Growth (YoY)
24.1%
Profit Margin
-4.4%
Share & Embed Analysis
Last updated: June 23, 2026 8:14 PM ET
Data refreshes hourly during market hours. Next update: 9:14 PM
Data refreshes hourly during market hours. Next update: 9:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CERS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Dennis Green
SELL
127544 shares
2026-03-12
Richard J Benjamin
SELL
101740 shares
2026-03-12
Vivek K Jayaraman
SELL
165200 shares
2026-03-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 61 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 62 BUY |
